Literature DB >> 18282690

Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample.

Masashi Ikeda1, Nagahide Takahashi, Shinichi Saito, Branko Aleksic, Yuichiro Watanabe, Ayako Nunokawa, Yoshio Yamanouchi, Tsuyoshi Kitajima, Yoko Kinoshita, Taro Kishi, Kunihiro Kawashima, Ryota Hashimoto, Hiroshi Ujike, Toshiya Inada, Toshiyuki Someya, Masatoshi Takeda, Norio Ozaki, Nakao Iwata.   

Abstract

Systematic linkage disequilibrium (LD) mapping of 8p12-21 in the Icelandic population identified neuregulin 1 (NRG1) as a prime candidate gene for schizophrenia. However, results of replication studies have been inconsistent, and no large sample analyses have been reported. Therefore, we designed this study with the aim of assessing this putative association between schizophrenia and NRG1 (especially HAP(ICE) region and exon region) using a gene-based association approach in the Japanese population. This study was a two-stage association analysis with a different panel of samples, in which the significant association found in the first-set screening samples (1126 cases and 1022 controls) was further assessed in the confirmation samples (1262 cases and 1172 controls, and 166 trio samples). In the first-set scan, 60 SNPs (49 tagging SNPs from HapMap database, four SNPs from other papers, and seven SNPs detected in the mutation scan) were examined. One haplotype showed a significant association in the first-set screening samples (Global P-value=0.0244, uncorrected). However, we could not replicate this association in the following independent confirmation samples. Moreover, we could not find sufficient evidence for association of the haplotype identified as being significant in the first-set samples by imputing ungenotyped SNPs from HapMap database. These results indicate that the positionally and functionally attractive regions of NRG1 are unlikely to contribute to susceptibility to schizophrenia in the Japanese population. Moreover, the nature of our results support that two-stage analysis with large sample size is appropriate to examine the susceptibility genes for common diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282690     DOI: 10.1016/j.schres.2008.01.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population.

Authors:  Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  J Neural Transm (Vienna)       Date:  2008-09-02       Impact factor: 3.575

2.  Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism.

Authors:  M Shibuya; E Komi; R Wang; T Kato; Y Watanabe; M Sakai; M Ozaki; T Someya; H Nawa
Journal:  J Neural Transm (Vienna)       Date:  2010-06-05       Impact factor: 3.575

3.  Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Authors:  Emily Moon; Brandi Rollins; Andrea Mesén; Adolfo Sequeira; Richard M Myers; Huda Akil; Stanley J Watson; Jack Barchas; Edward G Jones; Alan Schatzberg; William E Bunney; Lynn E DeLisi; William Byerley; Marquis P Vawter
Journal:  Schizophr Res       Date:  2011-07-13       Impact factor: 4.939

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 5.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

6.  Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population.

Authors:  Sae Shiota; Mamoru Tochigi; Hiroko Shimada; Jun Ohashi; Kiyoto Kasai; Nobumasa Kato; Katsushi Tokunaga; Tsukasa Sasaki
Journal:  J Hum Genet       Date:  2008-08-14       Impact factor: 3.172

7.  Family-based association study of Neuregulin 1 with psychotic bipolar disorder.

Authors:  Fernando S Goes; Virginia L Willour; Peter P Zandi; Pamela L Belmonte; Dean F MacKinnon; Francis M Mondimore; Barbara Schweizer; Elliot S Gershon; Francis J McMahon; James B Potash
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

8.  Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform in Schizophrenia.

Authors:  Erika Pedrosa; Karen A Nolan; Radu Stefanescu; Pnina Herskovits; Pnina Hershcovitz; Tomas Novak; Ilja Zukov; Pavla Stopkova; Herbert M Lachman
Journal:  Neuropsychobiology       Date:  2009-06-10       Impact factor: 2.328

Review 9.  Personalized medicine in psychiatry: problems and promises.

Authors:  Uzoezi Ozomaro; Claes Wahlestedt; Charles B Nemeroff
Journal:  BMC Med       Date:  2013-05-16       Impact factor: 8.775

10.  A Study of the Association between SNP8NRG241930 in the 5' End of Neuroglin 1 Gene with Schizophrenia in a Group of Iranian Patients.

Authors:  Seyed Ali Mohamad Shariati; Mehrdad Behmanesh; Hamid Galehdari
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.